Navigation Links
Artificial cornea offers better results for infants, some blind patients

those children recovered some vision, sometimes remarkably so, and none had an infection or a problem with the implant. In the seven cases where the child was 4 years old or older and could explain to some degree how much he or she could see, every child could at least see fingers held at an arm's length, and some children improved to 20/30 vision.

"Finally, we seem to have a method in hand to improve the vision of these children, many of whom have endured several surgeries that have failed," said James Aquavella, M.D., the University of Rochester ophthalmologist who is pioneering the use of the implant and who operated on most of the children in the study.

"These are children for whom, until now, there really has not been a good option. While this study is somewhat small and these children need to be followed for more time, we have decided that for now this is the treatment of choice for children who have corneas that are cloudy or opaque. It's either do this, or do nothing," he added.

Aquavella is discussing the work at the Cornea Society meeting in Las Vegas, while pediatric ophthalmologist Matthew Gearinger, M.D., of the Eye Institute is presenting at AAO. The study overall included 23 separate procedures on 17 patients; most of the procedures were performed by Aquavella in Rochester, while four were done by Esen K. Akpek, M.D., of the Wilmer Eye Institute at Johns Hopkins University.

The work addresses vision problems in some of the toughest-to-treat children. Oftentimes, in addition to needing a new cornea, these children require treatment for other ongoing conditions like glaucoma, cataracts, and retinopathy. And in children, successful transplants can be more difficult to perform than in adults.

"The vibrancy of a child's immune system has been one of the main reasons why cornea transplants haven't worked well in children," said Gearinger. "The risk of rejection is huge, and it just goes up with every subsequ
'"/>

Source:University of Rochester Medical Center


Page: 1 2 3 4 5 6

Related biology news :

1. Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss
2. New Research Shows Artificial Light at Night Stimulates Breast Cancer Growth in Laboratory Mice
3. Artifical cornea lets woman blind 20 years see
4. Scientists characterize proteome of human cornea
5. Scientists discover why cornea is transparent and free of blood vessels, allowing vision
6. Study shows how herpes infects cornea, evades immune cells
7. Leading reason for corneal transplants comes into focus
8. An artificial cornea is in sight, thanks to biomimetic hydrogels
9. Protein offers way to stop microscopic parasites in their tracks
10. Gene silencing technique offers new strategy for treating, curing disease
11. Mosaic mouse technique offers a powerful new tool to study diseases and genetics

Post Your Comments:
(Date:11/26/2009)..., Ecologists have at last worked out a way of usi...e size of bird populations. This is the first time...n translated into accurate estimates of bird speci...ed in the British Ecological Society,s Journal of... it could lead to a major advance in our ability t...
(Date:11/26/2009)..., MRSA (methicillin-resistant Staphylococcus Aur... annihilation as low-temperature plasma prototype ...easy and unfailing bactericidal cocktails. , Two...ficient disinfection of healthy skin (e.g. hands a...eria can pose a lethal threat; and another to shoo...
(Date:11/25/2009)..., On September 11, firefighters, police officers ...fort in the World Trade Center complex. They battl... searched for survivors, tackled fires and evacuat...ontained an estimated 17,000 people. And making th...nications: frightened workers and their relatives ...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3CSIRO medal winners 10352 1CSIRO medal winners 10352 2CSIRO medal winners 10352 3Fear of being laughed at crosses cultural boundaries 10348 1Fear of being laughed at crosses cultural boundaries 10348 2Fear of being laughed at crosses cultural boundaries 10348 3Fear of being laughed at crosses cultural boundaries 10348 4Retail Health Clinics The Real Story 59443 1Retail Health Clinics The Real Story 59443 2
... JDRF said today that it has recognized the work o...accelerating the pace of science in understanding ... and on preventing or reversing the severe complic...e. , The recipients of the third annual Scholar...he Diabetes Center at the University of California...
... sclerosis (MS), neuroradiologists and neurologist...zburg have been able to visualize inflammatory tis...d up to now, with the aid of a new contrast medium...he scientists have published their results in the ...ain . , In particular at the early stage of the ...
...ermany have discovered that methadone, an agent us...ing killing power against leukemia cells, includin...r laboratory study, published in the August 1 issu...Association for Cancer Research, suggests that met..., especially in patients whose cancer no longer re...
Other Biology News:JDRF announces 2008 Scholar Award recipients 2JDRF announces 2008 Scholar Award recipients 3Multiple Sclerosis: new MRI contrast medium enables early diagnosis in animal model 2Lab study shows methadone breaks resistance in untreatable forms of leukemia 2
(Date:11/25/2009)...RATON, Fla., Nov. 25 For many busi...odyLogicMD. The nation,s largest and fastest grow...usively in medically supervised bioidentical horm...s network since November 2008 - from 21 to 36 p...ian-owned centers, including one in Puerto Rico, b...
(Date:11/25/2009)...-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: R...., president and chief executive officer, will pre...Conference. , ,Presentation details are as follow...ce,Date: Tuesday, December 1, 2009,Time: ...lace Hotel, New York, NY,Webcast: <a href=,http...
(Date:11/24/2009)...stment bank KTA Capital,s client Neuren Pharmaceut...rtible note private placement with a U.S. institut... by KTA Capital as Neuren,s exclusive placement ag...rk (PRWEB) November 23, 2009 -- The independent Ne... Capital") has announced that its client Neur...
(Date:11/24/2009)...re-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq...ference on Tuesday, December 1st at 1:45 PM GMT in...sten via live audio broadcast over the Internet av...ich.com/ . Users can click the "Webcast" icon to... Sigma-Aldrich is a leading Life Science and High...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
....Y., Jan. 6 Dedicated to the memory and scienti...eered the fields of angiogenesis and vasculogenesi...and neoplastic disease, the newly released special...c Research and Biology includes a series of pape...pre-eminent physician-scientists of his generation...
...., Jan. 6 Horizon Therapeutics, Inc., a,privately...he appointment of,Amy Grahn to vice president, cli...esident of operations. , "Amy and Iain bring v...prepare regulatory filings in the U.S. and Europe ...ation of our lead product candidate, HZT-501," sai...
...Jan. 6 Volcano Corporation,(Nasdaq: VOLC ), a l...of,products for the diagnosis and treatment of cor...at it will be participating in the 27th Annual J.P...ry 14. , The presentation by Scott Huennekens,... at 8:30 a.m., Pacific Standard Time (11:30 a.m., ...
Other Biology Technology:Festschrift Issue Honoring Judah Folkman, M.D. in Lymphatic Research and Biology 2Festschrift Issue Honoring Judah Folkman, M.D. in Lymphatic Research and Biology 3Horizon Therapeutics Announces Senior Management Appointments 2Horizon Therapeutics Announces Senior Management Appointments 3Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast 2
Stem Cell Expansion Media 1 from 3H Biomedical AB
Human TIMP-1 ELISpot Development Kit from R&D Systems
BD IMagnet 1 each from BD Biosciences Pharmingen
MHC Volume 1 from Promega
Biology Products: